ASCO 2022 Annual Meeting

  • June 3, 2022 - June 7, 2022
  • Chicago, IL

Biomica is delighted to participate at the 2022 ASCO Annual Meeting.

Biomica’s abstract, entitled “A rationally designed live bacterial consortium for the potentiation of immune checkpoint therapy in solid tumors,” was selected for a poster and presentation session at the conference.

This poster has also been selected for the 2022 GRASP Advocate Choice Award. GRASP, which stands for Guiding Researchers and Advocates to Scientific Partnerships, and is a patient-led organization that brings together patients, clinicians, and researchers to exchange ideas and learn from each other to accelerate scientific breakthroughs.

For more details and registration: www.ASCO.org

Back to all News

Highlighted News About Biomica

Jan 27, 2025

2025 J.P. Morgan Annual Healthcare week

Dr. Elran Haber, CEO of Biomica will be attending Biotech Showcase 2025 as part of the J.P. Morgan Annual Healthcare week in San Francisco. If you’d like to meet with Dr. Haber, please get in touch through the partnering platform or DM us.

Jan 27, 2025

Biomica’s Investor Meeting & Workshop

Biomica was delighted to host an inspiring investor meeting and workshop in Hong Kong, bringing together leading academics, local investors, researchers, and partners. Dr. Elran Haber, Biomica’s CEO, presented the company’s cutting-edge advancements in microbiome-based therapeutics, while Prof. Gal Markel shared his insights into the recent positive Ph1 results and the transformative potential of these […]

Jan 27, 2025

Microbiome Connect USA

Biomica’s CEO, Dr. Elran Haber, will be a featured panelist at the Microbiome Connect USA event on Wednesday, November 20, at 9:30 AM (local time). Join him for the session: “Taking the Bird’s Eye View: Market Insights & Dynamics of Microbiome Drug Development”.